Stockreport

OKYO Pharma to Present at OIS XV in San Diego [Yahoo! Finance]

OKYO Pharma Limited - Ordinary Shares  (OKYO) 
PDF bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-rela [Read more]